Cyteir completes financing to advance novel cancer therapies

By David E Shaw

As a co-founder of Cyteir Therapeutics, and chair emeritus of The Jackson Laboratory, I’m pleased to share this news about our Series B financing to advance novel cancer therapies. Cyteir was launched with technological breakthroughs discovered at The Jackson Laboratory.